Globus MedicalMEX:GMED 92 3-Year Revenue Growth Rate is 29.10% as of Mar. 2026, which is 210% above its 10-year median of 9.40. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,670.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 750 Medical Devices & Instruments companies, Globus Medical ranks better than 91.87% on this metric.
During the past 12 months, Globus Medical's average Revenue per Share Growth Rate was 25.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 29.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 23.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 13.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Globus Medical was 29.10% per year. The lowest was 4.20% per year. And the median was 9.40% per year.
Globus Medical (MEX:GMED) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Globus Medical 3-Year Revenue Growth Rate Related Terms
MEX:GMED vs PODD, PEN, MASI: 3-Year Revenue Growth Rate Comparison
For the Medical Devices subindustry, Globus Medical's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical 3-Year Revenue Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Globus Medical's 3-Year Revenue Growth Rate falls into.
Globus Medical 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 29.10% mean?
Globus Medical (MEX:GMED) has a 3-Year Revenue Growth Rate of 29.10% as of Mar. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Globus Medical and its competitors. This is 210% above median its historical median of 9.40. Over the past decade, Globus Medical's 3-Year Revenue Growth Rate has ranged from 4.20 to 29.10. According to the industry distribution chart, Globus Medical ranks #61 out of 750 companies in the Medical Devices & Instruments industry, placing it in the top 8.1%.
Is Globus Medical's 3-Year Revenue Growth Rate too high?
Globus Medical's current 3-Year Revenue Growth Rate of 29.10% is 210% above median its 10-year median of 9.40. Over the past 10 years, this metric has ranged from a low of 4.20 to a high of 29.10. The Medical Devices & Instruments industry median 3-Year Revenue Growth Rate is 3.65. Globus Medical's value of 29.10% is 697.3% above this industry median. Based on the distribution chart, Globus Medical ranks #61 out of 750 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's 3-Year Revenue Growth Rate compare to PODD and PEN?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #61 out of 750 companies for 3-Year Revenue Growth Rate. This places Globus Medical in the top 8% of its industry — outperforming the majority of peers. The industry median 3-Year Revenue Growth Rate is 3.65. Globus Medical's value of 29.10% is 697.3% above this benchmark. Historically, Globus Medical's own 3-Year Revenue Growth Rate has ranged from 4.20 to 29.10 over the past decade. While the company's 10-year median is 9.40 vs. the industry median of 3.65, Globus Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Revenue Growth Rate among Medical Devices & Instruments companies is 3.65, based on 750 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current 3-Year Revenue Growth Rate of 29.10% is 697.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Revenue Growth Rate is 3.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current 3-Year Revenue Growth Rate is 29.10%, which is 210% above median its own 10-year median of 9.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,670.17, compared to a current price of MXN1,355.65 — trading 18.8% below its estimated fair value. The current 3-Year Revenue Growth Rate is 29.10%, which is 210% above median its 10-year median of 9.40 and 697.3% above the Medical Devices & Instruments industry median of 3.65. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current 3-Year Revenue Growth Rate is 29.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,355.65 is trading 18.8% below its estimated GF Value™ of MXN1,670.17.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
3-Year Revenue Growth Rate: 29.10% (210% above median its 10-year median of 9.40)
GF Value™: MXN1,670.17 vs. price of MXN1,355.65 (18.8% below fair value)
Industry Position: 697.3% above the Medical Devices & Instruments median (#61 of 750)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score
Get the complete analysis for MEX:GMED
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 